This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Kidney Transplantation
and you are
over 18
years old
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

The present study will examine whether serum FGF-23 and serum phosphate at baseline of kidney transplant recipients can predict progression of allograft dysfunction at 3 years and all-cause mortality at 5 years.
Tris trial is registered with FDA with number: NCT00903578. The sponsor of the trial is Ramathibodi Hospital and it is looking for 200 volunteers for the current phase.
Official trial title:
Impact of FGF-23 and Serum Phosphate on Allograft Function and Mortality in Kidney Allograft Recipients